EQT Life Sciences is pleased to announce that the LSP 7 fund ("EQT Life Sciences") has exited its minority stake in Tubulis (the "Company"), a Germany-based, clinical-stage biotechnology company ...

At SAS Innovate 2026, SAS will unveil health care and life sciences analytics and AI capabilities and share real-world ...

April 01, 2026 - PRESSADVANTAGE - As clinical research, pharmaceutical development, and medical device innovation ...

The partnership with PAR Systems further strengthens SORBA.ai’s global ecosystem of automation providers, system integrators, ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...

By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...

Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing ...

Cancer innovation advances in many ways, but real impact depends on the ability to translate progress into care that is ...

New executives bring product, regulatory, and life sciences expertise to grow Arcadia’s impact across healthcare ...

Kezar Life Sciences Inc. (NASDAQ:KZR) shares jumped about 19% on Monday after Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ...

Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed and closed at its hard cap of $6.3 billion of total capital commitments. It ...